ID1 and breast neoplasm: While there is no consensus as to the prognostic impact of ID2 expression in breast tumors, relatively high ID1 expression has consistently been associated with poor prognosis (Lasorella et al., 2014) and, consequently, with invasive and metastatic capacities (Fong et al., 2003).